Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 897249, 11 pages
http://dx.doi.org/10.1155/2014/897249
Research Article

Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4+ T Cells of Patients with Relapsing-Remitting Multiple Sclerosis

Clinical Neuroimmunology, Departments of Biomedicine and Neurology, University Hospital Basel, Hebelstrasse 20, 4031 Basel, Switzerland

Received 28 November 2013; Accepted 28 March 2014; Published 12 May 2014

Academic Editor: Silvia Sánchez-Ramón

Copyright © 2014 Maria Meira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Maria Meira, Claudia Sievers, Francine Hoffmann, et al., “Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4+ T Cells of Patients with Relapsing-Remitting Multiple Sclerosis,” Journal of Immunology Research, vol. 2014, Article ID 897249, 11 pages, 2014. https://doi.org/10.1155/2014/897249.